Investegate |Galapagos NV Announcements | Galapagos NV: Gala

Investegate announcements from Galapagos NV, Galapagos initiates Phase 3 program with filgotinib in patients with active axial spondyloarthritis

Related Keywords

Ruhr , Nordrhein Westfalen , Germany , United Kingdom , Belgium , Japan , Bochum , Mechelen , Region Flamande , Northern Ireland , Craigavon , Great Britain , Japanese , Van Gijsel , Daniele Dambrosio , Marieke Vermeersch , Xenofon Baraliakos , Elisa Chenailler , Sandra Cauwenberghs , Percentage Of Participants Achieving Spondyloarthritis International Society , European Union , Japanese Ministry Of Health , Gilead Sciences Inc , University Bochum , Exchange Commission , European Medicines Agency , Axspa Topline , Ankylosing Spondylitis Disease Activity Score , Internal Medicine , Ruhr University Bochum , Coordinating Investigator , Danieled Ambrosio , Therapeutic Area Head , European Summary , Product Characteristics , Great Britain Summary , Northern Ireland Summary , Japanese Ministry , Gilead Sciences , Annual Report , Ankylosing Spondylitis , Der Heijde , Investegate Announcements , Investegate Company Announcements , Galapagos Nv , Lobenewswire , Lobenewswire And Globenewswire , Nw ,